iBio Inc (IBIO)

May 25, 2026

Top iBio (IBIO) Competitors 2026 - MarketBeat

May 25, 2026

May 19, 2026

iBio (IBIO) director receives 60,000 stock options vesting over 3 years - Stock Titan

May 19, 2026

May 15, 2026

Logos Global reports zero ownership in iBio (NASDAQ: IBIO) - Stock Titan

May 15, 2026

May 15, 2026

Point72, Steven A. Cohen report 0% in iBio (IBIO) amendment - Stock Titan

May 15, 2026

May 15, 2026

EcoR1 and Oleg Nodelman report 1.58M shares in iBio (NASDAQ: IBIO) - Stock Titan

May 15, 2026

May 15, 2026

Cormorant (IBIO) reports 3.83M shares, holds near-10% via warrants - Stock Titan

May 15, 2026

May 15, 2026

Leerink Partners Maintains IBio Inc(IBIO.US) With Buy Rating, Raises Target Price to $6 - Moomoo

May 15, 2026

May 15, 2026

iBio (NASDAQ: IBIO) — Sirenia/Manager report 11.59M shares, near 10% cap - Stock Titan

May 15, 2026

May 15, 2026

Elizabeth Stoner joins iBio (IBIO) board and files initial Form 3 - Stock Titan

May 15, 2026

May 15, 2026

We're Not Very Worried About iBio's (NASDAQ:IBIO) Cash Burn Rate - Yahoo Finance

May 15, 2026

May 15, 2026

IBIO Should I Buy - Intellectia AI

May 15, 2026

May 14, 2026

iBio (IBIO) adviser and manager report a 9.99% beneficial stake - Stock Titan

May 14, 2026

May 14, 2026

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ibio (IBIO), MaxCyte (MXCT) and Atea Pharmaceuticals (AVIR) - The Globe and Mail

May 14, 2026

May 14, 2026

Insider Traders Lose US$19k As iBio Drops - simplywall.st

May 14, 2026

May 13, 2026

iBio, Inc. Stock 12‑Month Price Target Raised to $5.53, Implies 244% Upside - TradingView

May 13, 2026

May 13, 2026

IBio 3Q Rev $0.00 >IBIO - Moomoo

May 13, 2026

May 13, 2026

Intelligent Bio Solutions Reports 46% Revenue Growth in Q3 FY202 - GuruFocus

May 13, 2026

May 12, 2026

IBIO Achieves Key Milestones in Obesity Treatment Development - GuruFocus

May 12, 2026

May 12, 2026

IBio reports Q3 fiscal year 2026 financial results and provides corporate update - marketscreener.com

May 12, 2026

May 12, 2026

iBio Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2026

May 12, 2026

Frazier funds disclose holdings and warrants in iBio (NASDAQ: IBIO) - Stock Titan

May 12, 2026

May 12, 2026

iBio Reports Q3 Fiscal Year 2026 Financial Results and Provides Corporate Update - The Manila Times

May 12, 2026

May 12, 2026

IBio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026 - marketscreener.com

May 12, 2026

May 12, 2026

iBio (IBIO) raises $74.8M in cash and investments while net loss reaches $22.4M - Stock Titan

May 12, 2026

May 12, 2026

iBio (Nasdaq: IBIO) widens Q3 loss, boosts cash to fund pipeline into 2028 - Stock Titan

May 12, 2026

May 12, 2026

IBio Extends Cash Runway Into 4Q of Fiscal Yr 2028 - Moomoo

May 12, 2026

May 11, 2026

TradingKey - TradingKey

May 11, 2026

May 11, 2026

Number of shareholders of iBio, Inc. – NASDAQ:IBIO - TradingView

May 11, 2026

May 11, 2026

IBIO Stock Price, Quote & Chart | IBIO INC (NASDAQ:IBIO) - ChartMill

May 11, 2026

May 09, 2026

MSN Money - MSN

May 09, 2026

May 08, 2026

iBio Inc. (IBIO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

May 08, 2026

May 08, 2026

iBio Strengthens Board with Appointment of Dr. Stoner - TipRanks

May 08, 2026

May 08, 2026

Veteran biotech executive joins iBio (NASDAQ: IBIO) board as Class II director - Stock Titan

May 08, 2026

May 08, 2026

iBio Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView

May 08, 2026

May 08, 2026

iBio appoints Elizabeth Stoner to board of directors By Investing.com - Investing.com Australia

May 08, 2026

May 08, 2026

iBio appoints Elizabeth Stoner to board of directors - Investing.com

May 08, 2026

May 08, 2026

iBio, Inc. Appoints Dr. Elizabeth Stoner to Board of Directors - Quiver Quantitative

May 08, 2026

May 08, 2026

iBio Appoints Distinguished Biotech Leader, Elizabeth Stoner, to its Board of Directors - The Manila Times

May 08, 2026

May 08, 2026

Biotech veteran Elizabeth Stoner joins iBio board ahead of first human trial - Stock Titan

May 08, 2026

May 01, 2026

iBio, Inc. (NASDAQ:IBIO) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat

May 01, 2026

Apr 29, 2026

iBio (NASDAQ: IBIO) substitutes SILV Fund after 876,340‑share transfer - Stock Titan

Apr 29, 2026

Apr 27, 2026

IBIO stock is soaring today after iBio's muscle-preserving drug receives approval for human trial in Australia - MSN

Apr 27, 2026

Apr 26, 2026

IBIO (IBIO) price target increased by 18.73% to 5.47 - MSN

Apr 26, 2026

Apr 24, 2026

iBio (IBIO) Receives Regulatory Clearance to Initiate Phase 1 Trial of IBIO-600 - Yahoo Finance

Apr 24, 2026

Apr 24, 2026

10 Best NASDAQ Growth Stocks to Buy and Hold Forever - Insider Monkey

Apr 24, 2026

Apr 23, 2026

IBIO (iBio Inc.) falls 2.37% today after Q1 2026 EPS lands slightly below consensus estimates.Revenue Guidance - Xã Châu Thành

Apr 23, 2026

Apr 22, 2026

IBIO (iBio Inc.) reports 77.8 percent year over year Q1 2026 revenue growth, shares edge higher.Growth Acceleration - Cổng thông tin điện tử Tỉnh Sơn La

Apr 22, 2026

Apr 18, 2026

iBio, Inc. 8-K/A Filing Details: Company Information, Address, and Stock Listing (April 8, 2026) - Minichart

Apr 18, 2026